|
|
Blood, 15 April 2005, Vol. 105, No. 8, pp. 3178-3184.
Prepublished online as a Blood First Edition Paper on December 30, 2004; DOI 10.1182/blood-2004-10-3985.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1phosphate receptor-1 crossactivation
Clemens Feistritzer, and
Matthias Riewald
From the Department of Immunology, The Scripps Research Institute, La Jolla, CA.
Endothelial cells normally form a dynamically regulated barrier at the blood-tissue interface, and breakdown of this barrier is a key pathogenic factor in inflammatory disorders such as sepsis. Pro-inflammatory signaling by the blood coagulation protease thrombin through protease activated receptor-1 (PAR1) can disrupt endothelial barrier integrity, whereas the bioactive lipid sphingosine 1-phosphate (S1P) recently has been demonstrated to have potent barrier protective effects. Activated protein C (APC) inhibits thrombin generation and has potent anti-inflammatory effects. Here, we show that APC enhanced endothelial barrier integrity in a dual-chamber system dependent on binding to endothelial protein C receptor, activation of PAR1, and activity of cellular sphingosine kinase. Small interfering RNA that targets sphingosine kinase-1 or S1P receptor-1 blocked this protective signaling by APC. Incubation of cells with PAR1 agonist peptide or low concentrations of thrombin ( 40 pM) had a similar barrier-enhancing effect. These results demonstrate that PAR1 activation on endothelial cells can have opposite biologic effects, reveal a role for cross-communication between the prototypical barrier-protective S1P and barrier-disruptive PAR1 pathway, and suggest that S1P receptor-1 mediates protective effects of APC in systemic inflammation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
APC signaling: tickling PAR1 for barrier protection?
- Eric Camerer and Shaun R. Coughlin
Blood 2005 105: 3004-3005.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. Delvaeye and E. M. Conway
Coagulation and innate immune responses: can we view them separately?
Blood,
September 17, 2009;
114(12):
2367 - 2374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Song, X. Ye, H. Xu, and S. F. Liu
Activation of endothelial intrinsic NF-{kappa}B pathway impairs protein C anticoagulation mechanism and promotes coagulation in endotoxemic mice
Blood,
September 17, 2009;
114(12):
2521 - 2529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Van Sluis, T. M.H. Niers, C. T. Esmon, W. Tigchelaar, D. J. Richel, H. R. Buller, C. J.F. Van Noorden, and C. A. Spek
Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement
Blood,
August 27, 2009;
114(9):
1968 - 1973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Nayak, P. Sen, S. Ghosh, R. Gopalakrishnan, C. T. Esmon, U. R. Pendurthi, and L. V. M. Rao
Endothelial cell protein C receptor cellular localization and trafficking: potential functional implications
Blood,
August 27, 2009;
114(9):
1974 - 1986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Mann, M. A. Short, and D. E. Schlichting
Protein C in critical illness
Am. J. Health Syst. Pharm.,
June 15, 2009;
66(12):
1089 - 1096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. O. Mosnier, A. Zampolli, E. J. Kerschen, R. A. Schuepbach, Y. Banerjee, J. A. Fernandez, X. V. Yang, M. Riewald, H. Weiler, Z. M. Ruggeri, et al.
Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant
Blood,
June 4, 2009;
113(23):
5970 - 5978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Elphick, P. P. Sarangi, Y.-M. Hyun, J. A. Hollenbaugh, A. Ayala, W. L. Biffl, H.-L. Chung, A. R. Rezaie, J. L. McGrath, D. J. Topham, et al.
Recombinant human activated protein C inhibits integrin-mediated neutrophil migration
Blood,
April 23, 2009;
113(17):
4078 - 4085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Russo, U. J. K. Soh, M. M. Paing, P. Arora, and J. Trejo
Caveolae are required for protease-selective signaling by protease-activated receptor-1
PNAS,
April 14, 2009;
106(15):
6393 - 6397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bezuhly, R. Cullen, C. T. Esmon, S. F. Morris, K. A. West, B. Johnston, and R. S. Liwski
Role of activated protein C and its receptor in inhibition of tumor metastasis
Blood,
April 2, 2009;
113(14):
3371 - 3374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Russo, U. J. K. Soh, and J. Trejo
Proteases Display Biased Agonism at Protease-Activated Receptors: Location matters!
Mol. Interv.,
April 1, 2009;
9(2):
87 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wadgaonkar, V. Patel, N. Grinkina, C. Romano, J. Liu, Y. Zhao, S. Sammani, J. G. N. Garcia, and V. Natarajan
Differential regulation of sphingosine kinases 1 and 2 in lung injury
Am J Physiol Lung Cell Mol Physiol,
April 1, 2009;
296(4):
L603 - L613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Niessen, C. Furlan-Freguia, J. A. Fernandez, L. O. Mosnier, F. J. Castellino, H. Weiler, H. Rosen, J. H. Griffin, and W. Ruf
Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality
Blood,
March 19, 2009;
113(12):
2859 - 2866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Perez-Casal, C. Downey, B. Cutillas-Moreno, M. Zuzel, K. Fukudome, and C. H. Toh
Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects
Haematologica,
March 1, 2009;
94(3):
387 - 394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. S. Preston, S. Tran, J. A. Johnson, F. N. Ainle, S. Harmon, B. White, O. P. Smith, P. V. Jenkins, B. Dahlback, and J. S. O'Donnell
Platelet Factor 4 Impairs the Anticoagulant Activity of Activated Protein C
J. Biol. Chem.,
February 27, 2009;
284(9):
5869 - 5875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Bozza, A. M. Shah, A. S. Weyrich, and G. A. Zimmerman
Amicus or Adversary: Platelets in Lung Biology, Acute Injury, and Inflammation
Am. J. Respir. Cell Mol. Biol.,
February 1, 2009;
40(2):
123 - 134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gupta, B. Gerlitz, M. A. Richardson, C. Bull, D. T. Berg, S. Syed, E. J. Galbreath, B. A. Swanson, B. E. Jones, and B. W. Grinnell
Distinct Functions of Activated Protein C Differentially Attenuate Acute Kidney Injury
J. Am. Soc. Nephrol.,
February 1, 2009;
20(2):
267 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M R Looney, C T Esmon, and M A Matthay
Role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury
Thorax,
February 1, 2009;
64(2):
114 - 120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Chambers
Abnormal wound healing responses in pulmonary fibrosis: focus on coagulation signalling
Eur. Respir. Rev.,
December 1, 2008;
17(109):
130 - 137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Uhlig and E. Gulbins
Sphingolipids in the Lungs
Am. J. Respir. Crit. Care Med.,
December 1, 2008;
178(11):
1100 - 1114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thiyagarajan, J. A. Fernandez, S. M. Lane, J. H. Griffin, and B. V. Zlokovic
Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1
J. Neurosci.,
November 26, 2008;
28(48):
12788 - 12797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Harmon, R. J. S. Preston, F. N. Ainle, J. A. Johnson, M. S. Cunningham, O. P. Smith, B. White, and J. S. O'Donnell
Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement
J. Biol. Chem.,
November 7, 2008;
283(45):
30531 - 30539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tauseef, V. Kini, N. Knezevic, M. Brannan, R. Ramchandaran, H. Fyrst, J. Saba, S. M. Vogel, A. B. Malik, and D. Mehta
Activation of Sphingosine Kinase-1 Reverses the Increase in Lung Vascular Permeability Through Sphingosine-1-Phosphate Receptor Signaling in Endothelial Cells
Circ. Res.,
November 7, 2008;
103(10):
1164 - 1172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Nachman and S. Rafii
Platelets, Petechiae, and Preservation of the Vascular Wall
N. Engl. J. Med.,
September 18, 2008;
359(12):
1261 - 1270.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Toltl, S. Beaudin, P. C. Liaw, and and the Canadian Critical Care Translational Biolo
Activated Protein C Up-Regulates IL-10 and Inhibits Tissue Factor in Blood Monocytes
J. Immunol.,
August 1, 2008;
181(3):
2165 - 2173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Li, M. Stankovic, C. S. Bonder, C. N. Hahn, M. Parsons, S. M. Pitson, P. Xia, R. L. Proia, M. A. Vadas, and J. R. Gamble
Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1
Blood,
April 1, 2008;
111(7):
3489 - 3497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schouten, W. J. Wiersinga, M. Levi, and T. van der Poll
Inflammation, endothelium, and coagulation in sepsis
J. Leukoc. Biol.,
March 1, 2008;
83(3):
536 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Schuepbach, C. Feistritzer, L. F. Brass, and M. Riewald
Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin
Blood,
March 1, 2008;
111(5):
2667 - 2673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Riewald and R. A. Schuepbach
Protective Signaling Pathways of Activated Protein C in Endothelial Cells
Arterioscler Thromb Vasc Biol,
January 1, 2008;
28(1):
1 - 3.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. O'Brien, M. A. Richardson, S. F. Mehrbod, D. T. Berg, B. Gerlitz, A. Gupta, and B. W. Grinnell
Activated Protein C Decreases Tumor Necrosis Factor Related Apoptosis-Inducing Ligand by an EPCR- Independent Mechanism Involving Egr-1/Erk-1/2 Activation
Arterioscler Thromb Vasc Biol,
December 1, 2007;
27(12):
2634 - 2641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Bae, L. Yang, C. Manithody, and A. R. Rezaie
The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells
Blood,
December 1, 2007;
110(12):
3909 - 3916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. A. Komarova, D. Mehta, and A. B. Malik
Dual Regulation of Endothelial Junctional Permeability
Sci. Signal.,
November 13, 2007;
2007(412):
re8 - re8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. O. Mosnier, X. V. Yang, and J. H. Griffin
Activated Protein C Mutant with Minimal Anticoagulant Activity, Normal Cytoprotective Activity, and Preservation of Thrombin Activable Fibrinolysis Inhibitor-dependent Cytoprotective Functions
J. Biol. Chem.,
November 9, 2007;
282(45):
33022 - 33033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Omori, Y. Shikata, K. Sarai, N. Watanabe, J. Wada, N. Goda, N. Kataoka, K. Shikata, and H. Makino
Edaravone mimics sphingosine-1-phosphate-induced endothelial barrier enhancement in human microvascular endothelial cells
Am J Physiol Cell Physiol,
November 1, 2007;
293(5):
C1523 - C1531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Kerschen, J. A. Fernandez, B. C. Cooley, X. V. Yang, R. Sood, L. O. Mosnier, F. J. Castellino, N. Mackman, J. H. Griffin, and H. Weiler
Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C
J. Exp. Med.,
October 1, 2007;
204(10):
2439 - 2448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, J.-S. Bae, C. Manithody, and A. R. Rezaie
Identification of a Specific Exosite on Activated Protein C for Interaction with Protease-activated Receptor 1
J. Biol. Chem.,
August 31, 2007;
282(35):
25493 - 25500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ahamed, F. Niessen, T. Kurokawa, Y. K. Lee, G. Bhattacharjee, J. H. Morrissey, and W. Ruf
Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia
Blood,
June 15, 2007;
109(12):
5251 - 5259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-S. Li, L. Wu, and J. A. Fernandez
The Endothelial Protein C Receptor in Vascular Smooth Muscle Cells For Good or Bad?
Circ. Res.,
May 25, 2007;
100(10):
e86 - e86.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin
The cytoprotective protein C pathway
Blood,
April 15, 2007;
109(8):
3161 - 3172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Bae, L. Yang, C. Manithody, and A. R. Rezaie
Engineering a Disulfide Bond to Stabilize the Calcium-binding Loop of Activated Protein C Eliminates Its Anticoagulant but Not Its Protective Signaling Properties
J. Biol. Chem.,
March 23, 2007;
282(12):
9251 - 9259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Arora, T. K. Ricks, and J. Trejo
Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer
J. Cell Sci.,
March 15, 2007;
120(6):
921 - 928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Bae, L. Yang, and A. R. Rezaie
Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells
PNAS,
February 20, 2007;
104(8):
2867 - 2872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thiyagarajan, T. Cheng, and B. V. Zlokovic
Endothelial Cell Protein C Receptor: Role Beyond Endothelium?
Circ. Res.,
February 2, 2007;
100(2):
155 - 157.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ayala, D. J. Warejcka, M. Olague-Marchan, and S. S. Twining
Corneal Activation of Prothrombin to Form Thrombin, Independent of Vascular Injury
Invest. Ophthalmol. Vis. Sci.,
January 1, 2007;
48(1):
134 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Camerer and J. Trejo
Cryptic messages: Is noncoagulant tissue factor reserved for cell signaling?
PNAS,
September 26, 2006;
103(39):
14259 - 14260.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Leger, L. Covic, and A. Kuliopulos
Protease-Activated Receptors in Cardiovascular Diseases
Circulation,
September 5, 2006;
114(10):
1070 - 1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Stephenson, L. J. Toltl, S. Beaudin, and P. C. Liaw
Modulation of Monocyte Function by Activated Protein C, a Natural Anticoagulant
J. Immunol.,
August 15, 2006;
177(4):
2115 - 2122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Feistritzer, R. A. Schuepbach, L. O. Mosnier, L. A. Bush, E. Di Cera, J. H. Griffin, and M. Riewald
Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial Cells
J. Biol. Chem.,
July 21, 2006;
281(29):
20077 - 20084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Ruf
Flow perturbation is linked to endothelial par signaling.
Arterioscler Thromb Vasc Biol,
May 1, 2006;
26(5):
962 - 964.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Feistritzer, B. A. Mosheimer, D. H. Sturn, M. Riewald, J. R. Patsch, and C. J. Wiedermann
Endothelial Protein C Receptor-Dependent Inhibition of Migration of Human Lymphocytes by Protein C Involves Epidermal Growth Factor Receptor
J. Immunol.,
January 15, 2006;
176(2):
1019 - 1025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Li, X. Zheng, J.-M. Gu, G. L. Ferrell, M. Brady, N. L. Esmon, and C. T. Esmon
Extraembryonic expression of EPCR is essential for embryonic viability
Blood,
October 15, 2005;
106(8):
2716 - 2722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Hait, S. Sarkar, H. Le Stunff, A. Mikami, M. Maceyka, S. Milstien, and S. Spiegel
Role of Sphingosine Kinase 2 in Cell Migration toward Epidermal Growth Factor
J. Biol. Chem.,
August 19, 2005;
280(33):
29462 - 29469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Riewald and W. Ruf
Protease-activated Receptor-1 Signaling by Activated Protein C in Cytokine-perturbed Endothelial Cells Is Distinct from Thrombin Signaling
J. Biol. Chem.,
May 20, 2005;
280(20):
19808 - 19814.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|